Zoetis Inc. $ZTS Shares Acquired by Turtle Creek Wealth Advisors LLC

Key Points

• Turtle Creek Wealth Advisors LLC increased its holdings in Zoetis Inc. by 11.6%, owning a total of 36,649 shares worth approximately $5.7 million as of their latest SEC filing.
• Several analysts have updated their ratings for Zoetis, with Piper Sandler raising their price target to $215, while Stifel Nicolaus and less favorable ratings from other firms result in a consensus rating of "Hold".
• Zoetis announced a quarterly dividend of $0.50 to be paid on December 2nd, with an annualized yield of 1.4%, reflecting a payout ratio of 34.42%.

Turtle Creek Wealth Advisors LLC increased its holdings in Zoetis Inc. (NYSE:ZTS - Free Report) by 11.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 36,649 shares of the company's stock after buying an additional 3,800 shares during the period. Turtle Creek Wealth Advisors LLC's holdings in Zoetis were worth $5,715,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Nova Wealth Management Inc. bought a new stake in Zoetis in the 1st quarter valued at about $25,000. 1248 Management LLC bought a new stake in Zoetis in the 1st quarter valued at about $27,000. Saudi Central Bank bought a new stake in Zoetis in the 1st quarter valued at about $29,000. Cornerstone Planning Group LLC lifted its position in Zoetis by 79.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock valued at $30,000 after purchasing an additional 88 shares during the last quarter. Finally, REAP Financial Group LLC lifted its position in Zoetis by 201.5% in the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company's stock valued at $31,000 after purchasing an additional 131 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts recently weighed in on ZTS shares. Argus reiterated a "buy" rating and issued a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Piper Sandler boosted their price target on shares of Zoetis from $210.00 to $215.00 and gave the stock an "overweight" rating in a research report on Monday, August 11th. Stifel Nicolaus downgraded shares of Zoetis from a "buy" rating to a "hold" rating and dropped their price target for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. Leerink Partners downgraded shares of Zoetis from an "outperform" rating to a "market perform" rating and dropped their price target for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Finally, Leerink Partnrs downgraded shares of Zoetis from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 17th. Four investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $196.71.

Zoetis Stock Down 1.0%

NYSE ZTS opened at $142.08 on Thursday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The company's 50 day simple moving average is $148.89 and its 200 day simple moving average is $154.03. Zoetis Inc. has a 12 month low of $139.34 and a 12 month high of $196.55. The company has a market capitalization of $62.97 billion, a P/E ratio of 24.45, a PEG ratio of 2.30 and a beta of 0.90.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The business had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the firm earned $1.56 EPS. The business's revenue for the quarter was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis's payout ratio is presently 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.